Navigation Links
Nasendoscopy proves useful in predicting treatment success in sleep apnea patients
Date:6/4/2010

WESTCHESTER, Ill. According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, nasendoscopy may help dentists predict oral appliance therapy success in sleep apnea patients. Nasendoscopy involves a flexible endoscope being inserted through the nasal cavity. The tip of the scope is placed at the level of the velopharynx and oro-/hypopharynx.

OAT has been shown to be a safe and effective treatment for patients with obstructive sleep apnea (OSA). This therapy is indicated for use in patients with mild to moderate OSA on the basis of the apnea-hypopnea index (AHI). However, it has been reported that some patients with severe OSA also benefit from OAT. Such findings suggest that patients should not be selected for OAT based on AHI alone.

This Japan-based study included 21 severe OSA patients (AHI>30) comprised of 18 men and three women. OSA severity was diagnosed with overnight polysomnography (PSG). Subjects ranged from 35 to 78 years of age.

During the nasendoscopy, patients laid supine in a dental chair. Researchers observed changes in the width of the velopharynx and oro-/hypopharynx.

After several weeks of wearing an oral appliance during sleep, each subject took a second PSG with the device. AHI reduction rates from OAT were compared between patients who did and did not show throat widening during the nasendoscopy.

All severe OSA patients showed improved AHI following OAT. All subjects experienced oro-/hypopharyngeal widening, but only 16 subjects demonstrated velopharyngeal widening.

The AHI reduction rate for patients with velopharyngeal widening was 79 percent. The reduction rate for patients without velopharyngeal widening was 45 percent. The difference between the two groups was significant. The direction of the velopharyngeal widening, 'all-round' or 'lateral dominant,' was independent of patient response.

Results indicate that patients who showed velopharyngeal widening during a nasendoscopy responded most effectively to OAT. These findings suggest that velopharyngeal widening observed when advancing the mandible from the centric occlusal position is associated with better OAT outcome.

Lead author Yasuhiro Sasao, DDS, PhD, suggests that nasendoscopies can help dentists predict patient response to OAT, reducing waste of resources and time.

"In Japan, nasendoscopy is used in dentistry and medicine to diagnose or evaluate oral function such as speech and swallowing the system is simple and relatively inexpensive," said Sasao.


'/>"/>

Contact: Public Relations Coordinator Emilee McStay
emcstay@aadsm.org
708-492-0930 x9310
American Academy of Sleep Medicine
Source:Eurekalert

Related medicine news :

1. New gene therapy proves effective in treating severe heart failure
2. Radiation after mastectomy improves breast cancer survival
3. My1Stop.com Improves Customer Experience with Enhanced Online Printing Web Site Design
4. Human Extracellular Matrix Significantly Improves Device Biocompatibility
5. Henry Ford Hospital: New left-side heart pump improves right-side heart function
6. Home monitoring, Web-based tool improves blood pressure control
7. For Preemies, Better Use of Oxygen Improves Survival
8. Physical therapist-led exercise in patients in ICU improves function and decreases hospital stay
9. Calcium Scan Improves Heart Risk Prediction
10. Complete revascularization improves outcomes for CAD patients
11. BU Mature Nursing Student Proves Life Begins at Forty-Five
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College ... nursing professionals advance their careers. Beginning in the fall of 2017, Emmanuel’s program will ... in as few as 16 months and for as little as $14,528. These changes ...
(Date:4/24/2017)... ... 24, 2017 , ... Michael Vick announced his retirement earlier this year from ... overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, made ... the most career rushing yards by a quarterback (6,109) and the most rushing yards ...
(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director ... Communication of Education Research Award. The award honors scholars exemplary in their capacity ... a scholar who has demonstrated the capacity to deepen the public’s understanding and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
Breaking Medicine Technology: